Brooks Laboratories Sells Brooks Steriscience Shares for ₹106.33 Cr

Brooks Laboratories Ltd announced on June 19, 2026, that its Board of Directors has approved the sale of 51,220 equity shares in its subsidiary, Brooks Steriscience Limited, to Steriscience Specialties Private Limited. The sale, for a cash consideration of ₹20,760 per share, aggregates to approximately ₹106.33 crore. This transaction represents a partial monetization of the company's investment, not a complete divestment. Following the sale, Brooks Laboratories will retain 1,02,440 equity shares, representing 32.67% of Brooks Steriscience's paid-up share capital. The proceeds will be used to fund the company's growth strategy, including operational expansion and general corporate purposes.